Brief: Kane Biotech Receives Decisions To Grant For Two European Patents
29/07/2021 15:37
July 29 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH RECEIVES DECISIONS TO GRANT FOR TWO EUROPEAN
PATENTS PROVIDING BROAD PROTECTION OF COACTIV+™ TECHNOLOGY FOR
WOUND CARE, SKIN INFECTIONS AND PERSONAL CARE FORMULATIONS
Source text for Eikon: ID:nGNX5wj6v6
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update